You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Prolonged Release Tablets

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Healthy Trial in Cairo (Vesicare (Solifenacin Succinate 5 mg) & Betmiga (Mirabegron 50 mg) (Reference first dose), Mirfenacin MR

Completed
  • Healthy
  • Vesicare (Solifenacin Succinate 5 mg) & Betmiga (Mirabegron 50 mg) (Reference first dose)
  • +2 more
  • Cairo, Egypt
    Genuine Research Center GRC
Mar 2, 2023

Pharmacokinetics Trial in Prague (Metformin 1000 mg Prolonged Release Tablets (JSC Farmak, Ukraine), Glucophage® XR 1000 mg

Completed
  • Pharmacokinetics
  • Metformin 1000 mg Prolonged Release Tablets (JSC Farmak, Ukraine)
  • Glucophage® XR 1000 mg Prolonged Release Tablets
  • Prague, Czechia
    QUINTA-ANALYTICA s.r.o.
Nov 17, 2021

Pharmacokinetics Trial in Prague (Metformin 500mg prolonged release tablets (JSC Farmak, Ukraine), Glucophage® XR 500 mg

Completed
  • Pharmacokinetics
  • Metformin 500mg prolonged release tablets (JSC Farmak, Ukraine)
  • Glucophage® XR 500 mg prolonged release tablets (Merck Serono Ltd, UK)
  • Prague, Czechia
    QUINTA-ANALYTICA s.r.o.
Nov 17, 2021

Pharmacokinetics Trial in Prague (Metformin 1000 mg Prolonged Release Tablets (JSC Farmak, Ukraine), Glucophage® XR 1000 mg

Completed
  • Pharmacokinetics
  • Metformin 1000 mg Prolonged Release Tablets (JSC Farmak, Ukraine)
  • Glucophage® XR 1000 mg Prolonged Release Tablets (Merck Serono Ltd, UK)
  • Prague, Czechia
    QUINTA-ANALYTICA s.r.o.
Nov 9, 2021

Pharmacokinetics Trial in Prague (Metformin, prolonged-release tablets 500 mg (JSC Farmak, Ukraine), Glucophage® XR 500 mg

Completed
  • Pharmacokinetics
  • Metformin, prolonged-release tablets 500 mg (JSC Farmak, Ukraine)
  • Glucophage® XR 500 mg prolonged release tablets (Merck Serono Ltd, UK)
  • Prague, Czechia
    QUINTA-ANALYTICA s.r.o.
Nov 17, 2021

Preeclampsia Trial in Sweden (Metformin ER, Placebo)

Not yet recruiting
  • Preeclampsia
  • Metformin ER
  • Placebo
  • Falun, Sweden
  • +5 more
Sep 10, 2023

Healthy Trial in Arzo (Trazodone HCl - new polymer, Trazodone HCl - Contramid®)

Completed
  • Healthy
  • Trazodone HCl - new polymer
  • Trazodone HCl - Contramid®
  • Arzo, Switzerland
    CROSS Research S.A., Phase I Unit, Via F.A. Giorgioli 14 Phone:
Nov 15, 2021

Lower Urinary Tract Symptoms, Voiding Disorders, Pain Trial in Split (Tadalafil 5mg, Tamsulosin Hydrochloride 400 Microgram

Enrolling by invitation
  • Lower Urinary Tract Symptoms
  • +3 more
  • Tadalafil 5mg
  • +2 more
  • Split, Splitsko-dalmatinska, Croatia
    University hospital of Splity
Sep 11, 2022

Liver Transplantation Trial (Tacrolimus Sustained-release Capsules)

Not yet recruiting
  • Liver Transplantation
  • Tacrolimus Sustained-release Capsules
  • (no location specified)
Nov 25, 2023

Hypertension Trial in Dongguan (Felodipine sustained release tablets (trade name: plendil®), Felodipine Controlled Release

Active, not recruiting
  • Hypertension
  • Felodipine sustained release tablets (trade name: plendil®)
  • Felodipine Controlled Release Tablets
  • Dongguan, Guangdong, China
    Clinical Trial Centre of Dongguan Kanghua Hospital
Jan 31, 2023

Microvascular Angina, Coronary Vasospasm, Microvascular Ischemia of Myocardium Trial in Nijmegen, Eindhoven, Rotterdam

Recruiting
  • Microvascular Angina
  • +2 more
  • Diltiazem Hydrochloride
  • Placebo
  • Nijmegen, Gelderland, Netherlands
  • +2 more
Feb 25, 2021

Partial Seizure Trial in Tianjin (Brivaracetam tablets (50mg/ tablet, BRIVIACT®, UCB), Brivaracetam sustained-release tablets

Active, not recruiting
  • Partial Seizure
  • Brivaracetam tablets (50mg/ tablet, BRIVIACT®, UCB)
  • +2 more
  • Tianjin, Tianjin, China
    Tianjin Municipal People's Hospital
Jan 31, 2023

Abilify Prolonged Release Aqueous Suspension for IM Injection

Recruiting
  • Bipolar Disorder I
  • Abilify prolonged release aqueous suspension for IM injection (Aripiprazole)
  • Osaka, Japan
    Pharmacovigilance Department
Jan 23, 2023

Pediatric Kidney Disease Trial in Germany (Envarsus®, Prograf)

Recruiting
  • Pediatric Kidney Disease
  • Cologne, Germany
  • +3 more
Sep 26, 2023

Epilepsy Trial in Wuhan (Lacosamide Tablets, Lacosamide extended release tablets)

Not yet recruiting
  • Epilepsy
  • Lacosamide Tablets
  • Lacosamide extended release tablets
  • Wuhan, Hubei, China
    Union Hospital of Tongji Medical College of Huazhong University
Mar 15, 2023

Somatic Symptom Trial in Shanghai (toludesvenlafaxine HCl sustained-release tablets)

Not yet recruiting
  • Somatic Symptom
  • toludesvenlafaxine hydrochloride sustained-release tablets
  • Shanghai, Shanghai, China
    Shanghai Mental Health Center
May 6, 2023

Generalized Anxiety Disorder Trial in Beijing (Toludesvenlafaxine Hydrochloride Sustained-release Tablet 80mg,

Not yet recruiting
  • Generalized Anxiety Disorder
  • Toludesvenlafaxine Hydrochloride Sustained-release Tablet 80mg
  • +2 more
  • Beijing, China
    Peking University Sixth Hospital
Aug 1, 2023

Oxycodone Sustained-release Tablets for Moderate to Severe

Recruiting
  • Cancer Pain
  • +2 more
    • Zhengzhou, Henan, China
      Henan Cancer Hospital
    Jul 24, 2023

    Healthy Participants Trial in Overland Park (Treatment A: Emraclidine 30mg IR tablets (reference), Treatment B: Emraclidine 30mg

    Not yet recruiting
    • Healthy Participants
    • Treatment A: Emraclidine 30mg IR tablets (reference)
    • +3 more
    • Overland Park, Kansas
      Overland Park, Kansas
    Jun 28, 2023

    Crohn's Disease, Oral Ulcer Trial in Xi'an (Mesalazine Sustained-Release Tablets, Riboflavin Sodium Phosphate Injection)

    Withdrawn
    • Crohn's Disease
    • Oral Ulcer
    • Mesalazine Sustained-Release Tablets
    • Riboflavin Sodium Phosphate Injection
    • Xi'an, Shaanxi, China
      Xijing Hospital
    Jan 30, 2023

    Multiple Myeloma Trial in Uppsala (NEX-20A)

    Recruiting
    • Multiple Myeloma
    • Uppsala, Sweden
      CTC Clinical Research Consultants AB
    Dec 15, 2022

    Bioequivalence, Diabetes, Type 2 Trial in San Pedro Garza García (Sitagliptin/Metformin HCl 50/500 mg extended release

    Completed
    • Bioequivalence
    • Diabetes Mellitus, Type 2
    • Sitagliptin/Metformin HCl 50/500 mg extended release film-coated tablet
    • San Pedro Garza García, Nuevo León, Mexico
      Avant Santé Research Center S.A. de C.V.
    Nov 8, 2023

    Bioequivalence, Diabetes, Type 2 Trial in San Pedro Garza García (Sitagliptin/Metformin HCl 100/1000 mg extended release

    Completed
    • Bioequivalence
    • Diabetes Mellitus, Type 2
    • Sitagliptin/Metformin HCl 100/1000 mg extended release film-coated tablet
    • San Pedro Garza García, Nuevo León, Mexico
      Avant Santé Research Center S.A. de C.V.
    Nov 8, 2023

    Bioequivalence, Diabetes, Type 2 Trial in San Pedro Garza García (Sitagliptin/Metformin HCl 100/1000 mg extended release

    Completed
    • Bioequivalence
    • Diabetes Mellitus, Type 2
    • Sitagliptin/Metformin HCl 100/1000 mg extended release film-coated tablet
    • San Pedro Garza García, Nuevo León, Mexico
      Avant Santé Research Center S.A. de C.V.
    Nov 8, 2023

    Bioequivalence, Diabetes, Type 2 Trial in San Pedro Garza Garcia (Sitagliptin/Metformin HCl 50/500 mg extended release

    Completed
    • Bioequivalence
    • Diabetes Mellitus, Type 2
    • Sitagliptin/Metformin HCl 50/500 mg extended release film-coated tablet
    • San Pedro Garza Garcia, Nuevo León, Mexico
      Avant Santé Research Center S.A. de C.V.
    Nov 8, 2023